MENU
BIB
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS
ProShares Ultra Nasdaq Biotechnology (BIB) Ownership - Who owns ProShares Ultra Nasdaq Biotechnology?
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®... Show more
Category: #Trading
Profile
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Details
Group
Alternative Funds
Category
Trading
Net Assets
49530460.00
Fund Existence
about 15 years
Turnover
32.00
Capitalization
N/A
Yield
2.20
Total Expense Ratio
0.95
Investment Style
N/A
Risk (Beta)
1.26
Fundamentals
BIB
Net Assets
49.5M
Yield
2.20
Fund Existence
about 15 years
Total Expense Ratio
0.95
Turnover
32.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
1.26
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
1.14
Assets in Top Ten Holdings
54.7M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
49.5M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.75
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
270.00
Number of Net Holdings
276.00
Number of Short Holdings
6.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
78.56%
Gain YTD
-6.260
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Trading
Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com